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Abstract
Background: Visceral leishmaniasis (VL), a widely distributed systemic disease caused by infection with the Leishmania
donovani complex (L. donovani and L. infantum), is almost always fatal if symptomatic and untreated. A rapid point-of-care
diagnostic test for anti-Leishmania antibodies, the rK39-immunochromatographic test (rK39-ICT), has high sensitivity and
specificity in South Asia but is less sensitive in East Africa. One of the underlying reasons may be continent-specific
molecular diversity in the rK39 antigen within the L. donovani complex. However, a second reason may be differences in
specific IgG anti-Leishmania levels in patients from different geographical regions, either due to variable antigenicity or
immunological response.
Methodology/Principal Findings:We determined IgG titres of Indian and Sudanese VL patients against whole cell lysates of
Indian and Sudanese L. donovani strains. Indian VL patients had significantly higher IgG titres against both L. donovani
strains compared to Sudanese VL patients (p,0.0001). Mean reciprocal log10 50% end-point titres (1/log10t50) were i) 3.80
and 3.88 for Indian plasma and ii) 2.13 and 2.09 for Sudanese plasma against Indian and Sudanese antigen respectively (p,
0.0001). Overall, the Indian VL patients therefore showed a 46.8–61.7 -fold higher mean ELISA titre than the Sudanese VL
patients. The higher IgG titres occurred in children (,16 years old) and adults of either sex from India (mean 1/log10t50:
3.60–4.15) versus Sudan (mean 1/log10t50: 1.88–2.54). The greatest difference in IgG responses was between male Indian and
Sudanese VL patients of $ 16 years old (mean 1/log10t50: 4.15 versus 1.99 = 144-fold (p,0.0001).
Conclusions/Significance: Anti-Leishmania IgG responses among VL patients in Sudan were significantly lower than in
India; this may be due to chronic malnutrition with Zn2+ deficiency, or variable antigenicity and capacity to generate IgG
responses to Leishmania antigens. Such differential anti-Leishmania IgG levels may contribute to lower sensitivity of the
rK39-ICT in East Africa.
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Introduction
The great majority of the estimated 200,000 to 400,000 annual
new cases of visceral leishmaniasis (VL) occurs in six countries,
with India having the highest estimated incidence in the world
(146,700 to 282,800/year), Sudan having the highest in Africa
(15,700 to 30,300/year) and Brazil having the highest in the
Americas (4,200 to 6,300/year) [1]. In South Asia and East Africa,
VL is caused by the kinetoplastid protozoan Leishmania donovani,
transmitted by the sandfly vectors Phlebotomus argentipes in South
Asia and P. orientalis and P. martini in East Africa. Following
inoculation into the human host, the parasite disseminates through
the lymphatic and vascular systems. Some infected individuals
remain asymptomatic, but full-blown symptomatic VL with bone
marrow infiltration and hepatosplenomegaly is almost always fatal
if untreated [2].
The demonstration of L. donovani amastigotes in lymph node,
spleen or bone marrow tissue smears is the definitive diagnostic
method for infection, however due to the invasive nature and the
operational difficulties associated with these procedures, serolog-
ical assays have been developed. Serological (anti-Leishmania
antibody) tests include the enzyme-linked immunosorbent assay
(ELISA), indirect fluorescent antibody test (IFAT) and the direct
agglutination test (DAT) [3,4]. However, these antibody detection
tests remain positive for several months to years after drug
treatment and cure and therefore cannot readily diagnose relapse;
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such tests can also be positive in asymptomatic individuals living in
endemic areas and exposed to L. donovani infection yet with no
history of VL or subsequent progression to VL.
The lateral-flow rapid diagnostic ‘point-of-care’ immunochro-
matographic test (ICT) format based on the rK39 antigen derived
from a Brazilian isolate of Leishmania infantum (historically known as
L. chagasi) [5] has demonstrated high levels of sensitivity in South
Asia but is less effective in East Africa for diagnosis of VL [6,7]. A
new ICT, based on the synthetic gene rK28, has recently been
developed to overcome these limitations [8,9], and is currently
under evaluation. Underlying explanatory factors for the different
levels of rK39 diagnostic success observed across geographical
regions may be molecular divergence between East African L.
donovani kinesin gene homologues and the Brazilian L. infantum (L.
chagasi)-derived rK39 sequence [10], and/or may be due to
quantitative differences in the IgG titres generated against the
rK39 antigen between South Asian and East African VL-endemic
populations. Here, we compare anti-L. donovani IgG titres in cases
of active VL in children and adults of each sex from India and
Sudan against whole cell lysates of L. donovani strains from both
countries. We find striking differences between the anti-Leishmania
IgG titres of the two human populations.
Methods
Ethics statement
In India, comparative serology was approved by the Ethics
Committee of the Banaras Hindu University, Varanasi, India. In
Sudan the protocols were approved by the Ethical Research
Committee, Faculty of Medicine, University of Khartoum and the
National Health Research Ethics Committee, Federal Ministry of
Health. Written informed consent was obtained from all adult
subjects included in the study, or from the parents or guardians of
individuals less than 18 years of age. This research was also
covered by the London School of Hygiene and Tropical Medicine
Ethics Committee approval of the EC NIDIAG project.
Study populations
Sudan: plasma samples were obtained upon clinical presenta-
tion from active cases of VL in the Gedaref region in eastern
Sudan between July and September 2011. Patients were diagnosed
as positive for VL by a combination of bone marrow aspiration,
lymph node aspiration, or serology. India: plasma samples were
obtained upon clinical presentation from active cases of VL in
Bihar state, north-eastern India after 2009. Active VL patients
were diagnosed by identification of parasitologically-positive
splenic aspirates. All samples in Sudan were transported by
continuous cold chain with samples maintained at 4uC, to the
research laboratory at Suba University Hospital and there stored
at 280uC; similarly all samples in India were cold chain
transported at 4uC to the laboratory at Banaras Hindu University
and stored at 280uC.
Antigen preparation
Strains of L. donovani originating from Sudan (MHOM/SD/97/
LEM3458) and India (MHOM/IN/80/DD8) were cultured in
aMEM (Sigma, UK) supplemented as described [11]. Mid-to-late
log phase cultures were washed three times in phosphate-buffered
saline (PBS), followed by three cycles of flash-freezing in liquid
nitrogen and thawing in a cold water bath. Subsequently, cells
were subjected to three 30 sec 12-micron sonication cycles on ice
at 30 second intervals using a Soniprep 150 sonicator (MSE, UK).
Sonicates were centrifuged at 120006g for 1 min, and the
supernatant used as antigen. Protein concentrations in these
lysates were determined using the BCA Protein Assay kit (Fisher
Scientific, Loughborough, UK).
Anti-Leishmania donovani ELISA
The indirect L. donovani ELISA was performed using relatively
low antigen concentrations (0.2 mg/well) established by prior
ELISA checkerboard titrations (not shown), with the intention of
increasing ability to discriminate between patients generating high
and low IgG antibody responses. Lysates of the L. donovani DD8
(Indian) and LEM3458 (Sudanese) strains, diluted to 2 mg/ml in
35 mM NaHCO3/15 mM NaCO3 buffer (pH 9.6), were sepa-
rately added at 100 ml/well to 48 wells (A to H 1–6 or A to H
7–12) (see Figure 1) of Immulon 4HB ELISA plates (VWR,
Lutterworth, UK) and incubated overnight at 4uC. After washing
the plates three times using PBS containing 0.05% (vol/vol)
Tween 20 (Sigma, Gillingham, UK) (PBST), they were blocked
using 200 ml/well PBST containing 2% skimmed milk powder
(Premier International Foods, Spalding, UK) (PBSTM) at 37uC for
2 hr. After washing three times with PBST, serial four-fold 1:400
to 1:25,600 dilutions of VL plasma samples (Table 1, Figure 1)
(100 ml/well) in PBSTM were added to the plates and incubated at
37uC for 1 hr. Plasma samples from the two endemic countries
were assayed on the same plate against antigens of both Indian
and Sudanese strains and were matched for sex and age groups as
shown in Figure 1. Following six PBST washes, a 1:5,000 dilution
of peroxidase-labelled goat anti-human IgG (H+L) (Jackson
ImmunoResearch, West Grove, USA) prepared in PBSTM was
added at 100 ml/well and the plates incubated at 37uC for 1 hr.
Following six PBST washes, 50 mM phosphate/citrate buffer
(pH 5.0) containing 2 mM o-phenylenediamine HCl and 0.007%
(vol/vol) H2O2 (Sigma, UK) was added at 100 ml/well and
incubated in the dark at room temperature for 15 minutes. The
substrate reactions were then stopped by the addition of 2 M
H2SO4 (50 ml/well) and the ELISA plates were read at 490 nm
(Spectra Max 190, Molecular Devices, Sunnyvale, USA). Coeffi-
cients of variation (mean positive control readings (n = 4)/standard
deviation of positive control x 100) at dilutions of 1/400 and
1/1600 were calculated from simultaneous duplicate plates for
both Indian and Sudanese sera (most coefficients of variation were
less than 1%). Reference positive plasma controls were also used
on every plate (Figure 1). Samples that gave coefficients of
Author Summary
Visceral leishmaniasis (VL) is a systemic disease with
highest prevalence in South Asia, East Africa, and Brazil.
VL is caused by protozoan parasites of the Leishmania
donovani complex, transmitted to humans when an
infected sandfly takes a bloodmeal. Within the human
host, the parasites replicate within cells, particularly of
bone marrow and spleen. Without effective treatment,
symptomatic VL is usually fatal. Correct treatment depends
on accurate diagnosis, which is by detection of parasites or
specific antibodies. The rK39 rapid diagnostic test for
antibody is highly sensitive in South Asia but less so in East
Africa, for poorly understood reasons. Here, we have
directly compared the anti-Leishmania antibody response
in groups of VL patients from India and Sudan. We found a
strikingly higher anti-Leishmania antibody response in
Indian compared to Sudanese patients, which was also
seen when further analysed by age and sex of the patients.
Thus in addition to parasite factors, we have shown that
difference in antibody levels may contribute to the lower
sensitivity of antibody-based diagnosis for VL in Sudan.
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variation above 20% were repeated. Representative plasma
samples from Indian and Sudanese endemic healthy controls
and from cases of active VL were used as inter-assay controls.
These plasma samples were chosen in preliminary assays as having
median responses against the lysate obtained from the L. donovani
strain isolated from the corresponding region (data not shown). To
Figure 1. Design of assay for comparative ELISA serology. Serial four-fold dilutions of plasma samples from Indian and Sudanese VL patients
were reacted with whole cell lysates of L. donovani strains isolated from each country. Identically formatted plates were run in all cases. Unlabelled
wells were not used.
doi:10.1371/journal.pntd.0002675.g001
Table 1. Indian and Sudanese plasma study populations used in comparative serology against Leishmania donovani antigens.
Endemic region Sex Age (years) n Mean age in years (range; standard deviation)
India (n = 36) Male $16 10 33.4 (16–70; 17.45)
,16 8 12.8 (10–15; 1.67)
Female $16 8 30.5 (17–52; 12.22)
,16 10 12.8 (9–15; 2.20)
Sudan (n = 36) Male $16 10 22.2 (16–43; 9.17)
,16 8 9.8 (4–15; 4.1)
Female $16 7 35.6 (25–60; 12.35)
,16 11 8.1 (1–15; 4.55)
Total n = 72
doi:10.1371/journal.pntd.0002675.t001
Lower IgG Responses in Sudanese versus Indian VL
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maximize the chances of identifying differences in the IgG
responses against the two different L. donovani strains (Figure 2)
and between Indian and Sudanese VL patients of each sex and age
group ($ or,16 years old), the highest mean absorbance (Absmax)
value was determined for each data set, from which the Absmax/2
was determined for calculating the mean reciprocal log10 50%
end-point (1/log10t50) ELISA titres. This methodology has been
recommended for comparisons between high, low and non-
classical IgG responses of acute and convalescent phase samples
from both individuals and patient groups infected with another
pathogen [12,13]. This approach is more accurate than deter-
mining ELISA titres as either: i) single end-point values located on
the very trailing slope of the ELISA sigmoid curve (e.g. values that
are 2 standard deviations above the mean obtained using negative
control sera) or ii) the mean absorbance values obtained using
single serum dilutions (e.g. 1/100) [12]. In the latter case, the
limited use of absorbance values results in a low dynamic range of
data for comparisons [12].
Statistical analyses
Two sided independent sample t-tests were used to analyse the
data (SPSS INC. Armonk, NY: IBM Corp). Normality was
assessed using a three tiered approach. Shapiro-Wilk tests were
conducted first with subsequent evaluation of the data through
visual assessment and by calculating a z-score for skewness
(ZSkewness = Skewness-0/SE Skewness) as proposed by Ghasemi and
Zahediasl [14]. In the event of a violation of the assumption of
homogeneity of variance (homscedasticity), SPSS calculated a
corrected p value. Significance was set at the 5% level.
Results
Table 1 summarises the age and sex compositions of the Indian
and Sudanese VL patients who provided plasma for comparisons
of serological responses between the two endemic regions.
Comparison of Indian and Sudanese IgG isotype
responses
The mean overall Sudanese (n = 36) and Indian (n= 36) active
VL patients’ IgG responses, at each plasma dilution, against lysates
of L. donovani strains isolated from each endemic area, with 95%
confidence intervals (CIs) are shown in Figure 2. In a few
instances, the unforeseen low Sudanese titres required minor
extrapolation of curves to determine specific 1/log1050% end-
point titres but since homoscedasticity was obtained in each case a
correction factor was not required. Similar high mean maximum
absorbance (Absmax) values were obtained for the Indian VL
patients against both the Indian and Sudanese L. donovani strains.
However the Indian VL patients showed significantly higher IgG
titres against both the Sudanese (mean 1/log10t50: 3.88) and
Indian (mean 1/log10t50: 3.80) L. donovani strains than the
Sudanese VL patients (mean 1/log10t50: 2.09 and 2.13 respective-
ly) (Figure 2A and B, Table 2; two-sided independent sample
t-tests for both L. donovani strains: p,0.0001). Thus, overall the
Indian VL patients generated 46.8–61.7-fold higher IgG titres
than the Sudanese patients against the L. donovani strains (Table 2).
We further assessed whether there were differences in anti-L.
donovani IgG titres generated by the male and female Indian and
Sudanese VL patients of less than or greater than 16 years old
against both L. donovani strains. We again used the mean highest
absorbance (Absmax) value for each data set (Figure 3A to D) to
maximize the identification of differences in the mean IgG
responses, from which the Absmax/2 value was determined for
interpolating the mean 1/log10t50 IgG ELISA titres. We observed
that the male VL patients of $16 years old from India showed
higher Absmax values against both the Sudanese (Absmax 3.34) and
Indian (Absmax 3.33) antigens than the female Indian VL patients
of the same age group (Absmax 3.11 and 2.99, respectively)
(Figure 3C and D). This difference was less in the male and female
Indian VL patients of ,16 years old (Figure 3A and B).
Importantly, the Sudanese male and female children (,16 years
Figure 2. IgG anti-Leishmania responses are higher in Indian than Sudanese VL patients. The mean IgG responses are shown with 95% CI,
for 36 Indian (purple line with nodes) and 36 Sudanese (green line) patients with active VL, against lysates of L. donovani strains isolated from [A] India
or [B] Sudan. Comparative mean 1/log10t50 IgG titres and fold-differences are shown in Table 2. Statistical p values of,0.0001 were obtained for both
the Indian and Sudanese antigens.
doi:10.1371/journal.pntd.0002675.g002
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old) and adults all generated lower mean IgG ELISA titres against
both L. donovani strains than the corresponding Indian VL patient
sex/age groups (Figure 3A to D). These differences ranged from
11.5 to 144-fold (Table 2).
The Sudanese male VL patients less than 16 years old showed
the lowest fold-differences compared to the Indian male VL
patients of the same age group (12.9-fold and 11.5-fold against
Sudanese and Indian antigen respectively). In contrast, the
Sudanese male VL patients older than 16 years showed the
highest fold-difference with the Indian male patients of the same
age group (144-fold).
Discussion
According to a recent report from the World Health Organi-
sation, among the research priorities for human diseases caused by
infection with kinetoplastid protozoa is research on diagnostics for
case detection and characterisation [15]. For many years, the
rK39 antigen has been the only rapid diagnostic ICT in a lateral
flow system that is readily applicable for field diagnosis of VL and
that can be used with minimal training with no other equipment
or reagent. Despite high levels of sensitivity in South Asia, the
rK39 ICT has shown lower efficacy in East Africa, for reasons that
are not fully understood. The recent rK28 ICT, based on 2639
amino acid repeats of a Sudanese L. donovani-derived kinesin
homologue of rK39, flanked by HASPB sequences, has been
developed in an attempt to overcome the differential sensitivity of
rK39. Reduced efficacy in East Africa has also been reported for a
diagnostic test using another L. donovani antigen, rKE16 [7].
Different sensitivities of the rK39 ICT in South Asia and East
Africa may be explained by molecular divergence in diagnostic
antigen sequences of geographically disparate L. donovani strains
and/or reflect the different levels of overall IgG anti-Leishmania
response between human populations in VL endemic areas. We
have assessed the first of these factors, and demonstrated
substantial and regional specific antigen diversity [10], an
observation subsequently reported by others [16].
Differential serological responses among different ethnic groups
within the same geographical region have been reported
previously, for both bacterial and protozoal pathogens, although
generally without understanding of the genetic/biological expla-
nations. Higher responses were found against: Helicobacter pylori in
non-Japanese Brazilians than Japanese Brazilians [17]; Streptococcus
pyogenes superantigen in Polynesian than New Zealand Europeans
[18]; Plasmodium falciparum in Fulani than sympatric ethnic groups
in Burkina Faso [19]; P. falciparum in Austro-Asiatic than Tibeto-
Burman groups in north-east India [20]. Jensen et al [21] reported
comparatively higher anti-Plasmodium titres in subjects from Flores
(Indonesia) than in counterparts from southern Sudan. In the UK,
higher IgG levels were found in South Asian patients compared to
European counterparts in the context of cardiovascular disease
[22].
Here, we used comparative analysis of serological responses, as
applied elsewhere [12,13] to assess accurately differences in IgG
titres between VL patient cohorts from Bihar (India) and Gedaref
(Sudan). We have clearly shown that active VL patients from India
generated significantly higher anti-L. donovani IgG responses
against whole cell lysates of both Indian and Sudanese parasite
strains than active VL patients from Sudan. This may contribute
to the reduced sensitivity of the commercial rK39 ICT assay with
Sudanese versus Indian VL patients. We used soluble antigens
from Leishmania whole cell lysates in the comparative ELISAs. On
western blots human VL serum antibodies recognise multiple
antigens in such lysate preparations (data not shown). It is
therefore likely that Sudanese patients with active VL had reduced
IgG titres against several L. donovani promastigote antigens; we
have not yet determined whether the response to particular
antigens is depleted. Thus, it may be challenging to identify L.
donovani antigens that provide adequately high sensitivity and
specificity for East Africa. Whilst it would be of interest to extend
these comparisons to include IFAT, results from ELISA and IFAT
generally accord, and we therefore anticipate that the two tests will
give compatible data [23]. Detection of antigens in urine may
provide an alternative, non invasive approach, possibly giving
prognostic information [24,25]. In the same multi-centre trial
comparing rK39 dipstick sensitivity and specificity across South
Asia and East Africa, Boelaert et al. [6] also compared the KAtexH
test, which detects a Leishmania carbohydrate antigen in urine
Table 2. Mean reciprocal ELISA titres and fold differences of Indian and Sudanese VL patients by age, sex and antigen source.
Mean reciprocal 50% end-point titre
(1/log10t50) interpolated
from Absmax/2
Figure Sex Age
Antigen
source
Indian
plasma
Sudanese
plasma Fold difference p value (95% CI) p value (95% CI)
(Indian-Sudanese) Sex: M or F Both Sexes
2A Both All Sudan 3.88 2.09 61.7 - p,0.0001 (1.35–2.24)
2B Both All India 3.80 2.13 46.8 - p,0.0001 (1.29–2.06)
3A M ,16 Sudan 3.63 2.52 12.9 p,0.007 (0.356–1.87) p,0.0001 (0.929–2.21)
F ,16 Sudan 3.78 1.88 79.4 p,0.001 (0.898–2.91)
3B M ,16 India 3.60 2.54 11.5 p,0.004 (0.385–1.73) p,0.0001 (0.90–2.03)
F ,16 India 3.69 1.92 58.9 p,0.001 (0.883–2.66)
3C M $16 Sudan 4.15 1.99 144 p,0.0001 (1.45–2.87) p,0.0001 (1.38–2.67)
F $16 Sudan 3.95 2.09 72.4 p,0.02 (0.388–3.33)
3D M $16 India 4.03 2.02 102 p,0.0001 (1.53–2.48) p,0.0001 (1.36–2.40)
F $16 India 3.84 2.13 51.3 p,0.008 (0.539–2.89)
doi:10.1371/journal.pntd.0002675.t002
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[26,27]. Sensitivities in both regions were described as moderate to
very low, with the lowest in India and Nepal, although higher
sensitivities have been recently reported from Bangladeshi studies
[28–30].
We have not yet assessed antibody levels in patients with post-
kala azar dermal leishmaniasis (PKDL). This is of interest because
PKDL is a sequela of VL that displays markedly different
epidemiological features between regions, in Sudan occurring at
a higher frequency (.50%) and much sooner after VL than in
India (,10%) [31]. In Sudan and India the plasma was collected
at time of clinical presentation of VL and no obvious differences in
symptoms between the two cohorts were observed; further
comparisons would benefit from more precise grading of clinical
severity.
Whilst the active VL patient numbers used in our analysis were
relatively low, Indian males $16 years old with active VL
generated higher IgG responses than females of the same age
group, whereas Sudanese male VL patients $16 years old
generated lower IgG responses than females of the same age
group. These trends were not apparent in Indian or Sudanese
patients,16 years old. Differences in infection between males and
females in late teenage years and in adults may be attributable to
increased susceptibility of young and adult men [32]; testosterone
increases L. donovani infection in macrophages [33]. In Sudan VL is
a disease of extreme poverty with high incidence associated with
chronic malnutrition, displacement of populations and lack of
health care [1,34–39]. Particular ethnic groups, possibly with
greater genetic susceptibility, may be more affected within the
ethnically mixed Sudanese population [40,41].
Malnutrition is known to reduce both human innate and
acquired immune responses against parasitic diseases such as VL
[42,43]. Experimental models of protein, zinc and iron malnutri-
tion have shown reduced immune responses in L. infantum infected
mice and increased early visceralisation [44,45]. Of these, even
mild zinc deficiency has been extensively reported to: i) reduce T-
and B -cells in the blood and lymphoid tissues of humans, non-
human primates and other animals, ii) dramatically reduce both
T- and B- cell numbers in the bone marrow by .75%, iii)
dramatically reduced B-cell IgG production, particularly to T-
dependent antigens, by 90% and iv) reduce both T- and B- cell
proliferation, resulting in depletion through apoptosis [46]. More
specifically, zinc deficiency in mice was shown to block the
Figure 3. IgG anti-Leishmania responses are higher in Indian VL regardless of age, sex or antigen source. The mean IgG responses and
95% CI are shown for Indian (purple and orange lines) and Sudanese (blue and green lines) active VL patients against lysates of L. donovani strains
isolated from Sudan [A & C] or India [B & D]. Comparative mean 1/log10t50 IgG titres and fold-differences are given in Table 2.
doi:10.1371/journal.pntd.0002675.g003
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development of bone-marrow pre-B and immature B-cells,
resulting in reduced B lymphocytes in the spleen; pre-natal zinc
deficiency in monkeys and mice reduced lymphocyte numbers and
IgG concentrations and produced long-term suppression of IgM,
IgA and IgG. Zinc deficiency in mice also resulted in reduced B-
cell responses to recall antigens with which they had previously
been inoculated, thereby suggesting that T- and B- cell depletion
resulted in impaired immunological memory [46]. Thus, malnu-
trition with zinc deficiency, even if relatively mild and previously
encountered may play an important role in the significantly lower
IgG titres of the Sudanese patients.
Human interleukin-2 (IL-2) and signalling through its receptor
(IL-2R) play a critical role in both T- and B-cell proliferation and
induce the expression of the IL-2Ra gene in B cells, thereby
increasing B-cell responses to IL-2, antibody heavy and light chain
expression and antibody secretion [47]. Thus, single nucleotide
polymorphisms in the genes encoding IL-2 and its receptor (IL-
2Ra or IL-2Rb) chains significantly affect human IgG titres in
response to both inactivated and live attenuated vaccines (e.g. the
live attenuated measles-mumps-rubella (MMR) vaccine) [48,49].
While there have not been similar studies performed on Sudanese
populations, VL patients in eastern Sudan had a significant
association with two SNPs in the IL-2Rb gene, one of which
encoded a non-conserved amino acid substitution (G245R) in the
proximal membrane domain that was very likely to affect IL-2
signalling [50]. Thus, these SNPs and others located in the genes
that affect IL-2 expression, function and responses may have
contributed to the reduced IgG responses of Sudanese VL patients
observed in our study.
Human leukocyte antigen (HLA) polymorphisms in the genes
encoding the MHC class II (HLA-DR, -DP and -DQ) molecules
are known to have significant effects on IgG responses to vaccines
[48], infectious diseases, cancer, asthma and autoimmune diseases
[51–53]. Early studies did not however find a significant
association of HLA class II polymorphisms in VL patients in
either Tunisia or Brazil [54,55]. By contrast, in a more recent
study performed using VL patients’ samples from Brazil and India,
HLA-DRB1 and HLA-DQA1 were the only genes associated with
VL risk in both populations [56] but comparisons of anti-
L. donovani IgG titres between these groups or the control groups
were not performed. Since no similar HLA studies have been
performed on Sudanese VL patients, it is presently not yet known
whether polymorphisms in these genes may have contributed to
the significantly lower IgG titres observed in the Sudanese versus
Indian VL patients found in our study.
Thus, the significant differences in the anti-L. donovani IgG titres
found here between the Indian and Sudanese VL patients in this
study may result from a combination of environmental and genetic
factors, in which malnutrition with Zn2+ deficiency, differences in
IL-2 responses due to polymorphisms in IL-2 and its receptor
(IL-2Ra and IL-2Rb) genes and possibly HLA-DRB1 and HLA-
DQA1 genes are to date the most likely candidates.
We have presented here a direct ELISA comparison of
serological responses between VL patients from different endemic
regions (Sudan and India), and have shown a clear difference in
the levels of IgG anti-Leishmania antibodies. Comparative serolog-
ical responses could also be extended to samples from Brazilian
cases of VL to investigate their contribution to reported lower
sensitivity with rK39-based ICTs [7], despite this diagnostic
antigen being derived from a Brazilian L. infantum (L. chagasi),
dispersed from Iberian Europe [57]. Our data suggest that the
relative levels of ability to mount a humoral response against
Leishmania antigen between the different human populations may
be a significant contributory factor in the differing levels of
sensitivity reported for rapid diagnostic tests applied in both
regions, and argue for the design and development of a test more
suited to East Africa, guided by comparative genomics [10].
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